Naahaad Mukadam, PhD: The Future of Dementia Care

Video

An expert in Alzheimer disease describes some of the struggles dementia patients might be going through during the COVID-19 pandemic.

With the population aging, it might become increasingly important to mitigate some of the symptoms of dementia to prevent a public health crisis.

Recently, a team of investigators from the University College London (UCL), released a new report summarizing preventative dementia care and what steps should be taken to truly reduce the amount of people diagnosed with dementia.

According to the report, the age-specific incidence of dementia is decreasing in many countries, likely due to improvements in education, nutrition, health care, and lifestyle changes. This lends credence to the belief that there are a number of modifiable risk factors that can reduce the risk of developing dementia.

There were already 9 known risk factors for dementia: less education, hypertension, hearing impairment, smoking, obesity, depression, physical inactivity, diabetes, and low social contact.

The UCL researchers have added excessive alcohol consumption, traumatic brain injury, and air pollution to the list of modifiable risk factors for dementia.

The investigators believe the 12 risk factors account for approximately 40% of dementia cases around the world and should drive preventative measures to reduce dementia incidence.

In an interview with HCPLive®, Naahaad Mukadam, PhD, Division of Psychiatry, University College London, explained how the report could yield some policy changes around the world and how dementia patients could be struggling during the ongoing coronavirus disease 2019 (COVID-19) pandemic.

The study, "Dementia prevention, intervention, and care: 2020 report of the Lancet Commission," was published online in The Lancet.

Related Videos
Addressing HS Risks at the Genetic Level, with Kai Li, BSc
Maternal Hidradenitits Suppurativa Linked to Neonatal Mortality, Pediatric Hospitalization Risk
Nanette B. Silverberg, MD: Uncovering Molluscum Epidemiology
Reviewing 2023 with FDA Commissioner Robert M. Califf, MD
A Year of RSV Highs and Lows, with Tina Tan, MD
Gestational Low-Dose Aspirin Does Not Increase Risk of IBD Flares in Women
Ryan A. Smith, MD: RSV Risk in Patients with IBD
Karen Shen, PhD: How COVID-19 Impacted Nursing Homes Staff Turnover Rates
Karen Shen, PhD: High Turnover Rates in Nursing Homes
Riha Bhatt, MD: Mimickers and Concurrent Diseases in Pediatric IBD
© 2024 MJH Life Sciences

All rights reserved.